Imatinib is introduced in the medical industry as the first member of a new class of agents. Widely used for treating certain types of cancer, this medicine inhibits a certain enzyme, a characteristic of a particular cancer cell and does not non- specifically inhibits and kills all rapidly dividing cells. This medicine is primarily indicated for gastrointestinal stromal tumors (GISTs), chronic myelogenous leukemia (CML) and other cancers. This medicine directly binds itself to the site of tyrosine kinase activity.
VEA IMPEX is engaged in Export of Pharmaceutical Products (Branded Generics, Specialty Products) to global markets. Over one and half decade of experience in exports of pharmaceutical products and the distribution industry has helped us build strong relationships with our suppliers. Our learning and growing process is ever evolving, as we are moving hand in hand with our old partnerships and also making new alliances. We work for companies that follow international standards under the conditions of Good Manufacturing Practice (GMP), so the quality is of the high standards. This ensures that quality products are supplied to the clients. Health care professionals around the world can depend upon us, as our pharmaceutical exports division sources and supplies branded medicines to them as and when required. Generic Pharmaceutical Medicines manufactured under Product Licence / Marketing Authorisations can also be arranged for the clients. Our team is fully equipped to cater to needs for documentations as required for registrations in overseas countries.
- BUSINESS TYPE Exporter, Service Provider, Supplier, Trading Company, Wholesaler
- EMPLOYEE COUNT 15
- ESTABLISHMENT 2014
- ANNUAL TURNOVER Rs 100 Lakhs
- WORKING DAYS Monday To Saturday
- GST NO 27AALFV8912H1ZP